Home
What's new
Latest activity
Authors
Store
Latest reviews
Search products
Forums
New posts
Search forums
What's new
New posts
New listings
New products
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Cart
Cart
Loading…
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Search titles only
By:
Menu
Log in
Register
Navigation
Install the app
Install
More options
Change style
Contact us
Close Menu
Forums
SVTPerformance's Chain of Restaurants
Road Side Pub
Marijuana, what say you
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Pribilof" data-source="post: 16915297" data-attributes="member: 155968"><p>[URL unfurl="true"]https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804653[/URL]</p><p></p><p>Key Points</p><p><strong>Question</strong> Is medical cannabis treatment associated with improvements in health-related quality of life?</p><p></p><p><strong>Findings</strong> In this case series of 3148 patients, significant improvements were reported on all 8 domains of the 36-Item Short Form Health Survey health-related quality of life assessment after commencing treatment with medical cannabis. Improvements were largely sustained over time.</p><p></p><p><strong>Meaning</strong> These findings suggest that medical cannabis treatment may be associated with improvements in health-related quality of life among patients with a range of health conditions.</p><p></p><p><strong>Results</strong> In this case series of 3148 patients, 1688 (53.6%) were female; 820 (30.2%) were employed; and the mean (SD) age was 55.9 (18.7) years at baseline before treatment. Chronic noncancer pain was the most common indication for treatment (68.6% [2160 of 3148]), followed by cancer pain (6.0% [190 of 3148]), insomnia (4.8% [152 of 3148]), and anxiety (4.2% [132 of 3148]). After commencing treatment with medical cannabis, patients reported significant improvements relative to baseline on all 8 domains of the SF-36, and these improvements were mostly sustained over time. After controlling for potential confounders in a regression model, treatment with medical cannabis was associated with an improvement of 6.60 (95% CI, 4.57-8.63) points to 18.31 (95% CI, 15.86-20.77) points in SF-36 scores, depending on the domain (all <em>P</em> < .001). Effect sizes (Cohen <em>d</em>) ranged from 0.21 to 0.72. A total of 2919 adverse events were reported, including 2 that were considered serious.</p><p></p><p><strong>Conclusions and Relevance</strong> In this case series study, patients using medical cannabis reported improvements in health-related quality of life, which were mostly sustained over time. Adverse events were rarely serious but common, highlighting the need for caution with prescribing medical cannabis.</p></blockquote><p></p>
[QUOTE="Pribilof, post: 16915297, member: 155968"] [URL unfurl="true"]https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804653[/URL] Key Points [B]Question[/B] Is medical cannabis treatment associated with improvements in health-related quality of life? [B]Findings[/B] In this case series of 3148 patients, significant improvements were reported on all 8 domains of the 36-Item Short Form Health Survey health-related quality of life assessment after commencing treatment with medical cannabis. Improvements were largely sustained over time. [B]Meaning[/B] These findings suggest that medical cannabis treatment may be associated with improvements in health-related quality of life among patients with a range of health conditions. [B]Results[/B] In this case series of 3148 patients, 1688 (53.6%) were female; 820 (30.2%) were employed; and the mean (SD) age was 55.9 (18.7) years at baseline before treatment. Chronic noncancer pain was the most common indication for treatment (68.6% [2160 of 3148]), followed by cancer pain (6.0% [190 of 3148]), insomnia (4.8% [152 of 3148]), and anxiety (4.2% [132 of 3148]). After commencing treatment with medical cannabis, patients reported significant improvements relative to baseline on all 8 domains of the SF-36, and these improvements were mostly sustained over time. After controlling for potential confounders in a regression model, treatment with medical cannabis was associated with an improvement of 6.60 (95% CI, 4.57-8.63) points to 18.31 (95% CI, 15.86-20.77) points in SF-36 scores, depending on the domain (all [I]P[/I] < .001). Effect sizes (Cohen [I]d[/I]) ranged from 0.21 to 0.72. A total of 2919 adverse events were reported, including 2 that were considered serious. [B]Conclusions and Relevance[/B] In this case series study, patients using medical cannabis reported improvements in health-related quality of life, which were mostly sustained over time. Adverse events were rarely serious but common, highlighting the need for caution with prescribing medical cannabis. [/QUOTE]
Insert quotes…
Verification
Post reply
Forums
SVTPerformance's Chain of Restaurants
Road Side Pub
Marijuana, what say you
Top